Transcript profiling of different types of multiple sclerosis lesions yields FGF1 as a promoter of remyelination

Acta Neuropathologica Communications

Volumn 2, Issue 1, 2014, Pages

  Mohan, Hema ^a,j   Friese, Anita ^a   Albrecht, Stefanie ^b   Krumbholz, Markus ^a   Elliott, Christina L ^c   Arthur, Ariel ^c   Menon, Ramesh ^d   Farina, Cinthia ^d   Junker, Andreas ^e   Stadelmann, Christine ^e   Barnett, Susan C ^c   Huitinga, Inge ^f   Wekerle, Hartmut ^g   Hohlfeld, Reinhard ^a,h   Lassmann, Hans ⁱ   Kuhlmann, Tanja ^b   Linington, Chris ^c   Meinl, Edgar ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d SAN RAFFAELE HOSPITAL   (Italy)

^e Institute of Neuropathology   (Germany)

^f NETHERLANDS BRAIN BANK   (Netherlands)

^g MAX PLANCK INSTITUTE OF NEUROBIOLOGY   (Germany)

^h Technische Universität München Munich Cluster for Systems Neurology   (Germany)

ⁱ Medical University of Vienna   (Austria)

^j UNIVERSITY OF MÜNSTER   (Germany)

more..

Author keywords

Demyelination; Fibroblast growth factor; Multiple sclerosis; Remyelination

Indexed keywords

FIBROBLAST GROWTH FACTOR 1; IL8 PROTEIN, HUMAN; INTERLEUKIN 8; LEUKEMIA INHIBITORY FACTOR; MESSENGER RNA;

ANIMAL; ASTROCYTE; BRAIN; C57BL MOUSE; CELL CULTURE; GENE EXPRESSION PROFILING; HUMAN; METABOLISM; MOUSE; MULTIPLE SCLEROSIS; MYELIN SHEATH; OLIGODENDROGLIA; PATHOPHYSIOLOGY; PHYSIOLOGY; SPINAL CORD; SPRAGUE DAWLEY RAT; TISSUE CULTURE TECHNIQUE; WHITE MATTER; WISTAR RAT;

ANIMALS; ASTROCYTES; BRAIN; CELLS, CULTURED; FIBROBLAST GROWTH FACTOR 1; GENE EXPRESSION PROFILING; HUMANS; INTERLEUKIN-8; LEUKEMIA INHIBITORY FACTOR; MICE; MICE, INBRED C57BL; MULTIPLE SCLEROSIS; MYELIN SHEATH; OLIGODENDROGLIA; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; RNA, MESSENGER; SPINAL CORD; TISSUE CULTURE TECHNIQUES; WHITE MATTER;

EID: 84964313433     PISSN: None     EISSN: 20515960     Source Type: Journal    
DOI: 10.1186/s40478-014-0168-9     Document Type: Article

References (80)

1. Tripathi RB, Rivers LE, Young KM, Jamen F, Richardson WD: NG2 glia generate new oligodendrocytes but few astrocytes in a murine experimental autoimmune encephalomyelitis model of demyelinating disease. J Neurosci 2010, 30(48):16383-16390. doi: 10.1523/jneurosci. 3411-10.2010
2. Franklin RJ: Why does remyelination fail in multiple sclerosis? Nature Rev Neurosci 2002, 3(9):705-714.
3. Piaton G, Williams A, Seilhean D, Lubetzki C: Remyelination in multiple sclerosis. Prog Brain Res 2009, 175: 453-464. doi: 10.1016/s0079-6123(09)17530-1
4. Redford EJ, Kapoor R, Smith KJ: Nitric oxide donors reversibly block axonal conduction: demyelinated axons are especially susceptible. Brain 1997, 120(Pt 12):2149-2157.
5. Nave KA, Trapp BD: Axon-glial signaling and the glial support of axon function. Annu Rev Neurosci 2008, 31: 535-561.
6. Funfschilling U, Supplie LM, Mahad D, Boretius S, Saab AS, Edgar J, Brinkmann BG, Kassmann CM, Tzvetanova ID, Mobius W, Diaz F, Meijer D, Suter U, Hamprecht B, Sereda MW, Moraes CT, Frahm J, Goebbels S, Nave KA: Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature 2012, 485(7399):517-521. doi: 10.1038/nature11007
7. Lee Y, Morrison BM, Li Y, Lengacher S, Farah MH, Hoffman PN, Liu Y, Tsingalia A, Jin L, Zhang PW, Pellerin L, Magistretti PJ, Rothstein JD: Oligodendroglia metabolically support axons and contribute to neurodegeneration. Nature 2012, 487(7408):443-448. doi: 10.1038/nature11314
8. Patani R, Balaratnam M, Vora A, Reynolds R: Remyelination can be extensive in multiple sclerosis despite a long disease course. Neuropathol Appl Neurobiol 2007, 33(3):277-287. doi: 10.1111/j.1365-2990.2007.00805.x
9. Patrikios P, Stadelmann C, Kutzelnigg A, Rauschka H, Schmidbauer M, Laursen H, Sorensen PS, Bruck W, Lucchinetti C, Lassmann H: Remyelination is extensive in a subset of multiple sclerosis patients. Brain 2006, 129(Pt 12):3165-3172.
10. Prineas JW, Barnard RO, Kwon EE, Sharer LR, Cho ES: Multiple sclerosis: remyelination of nascent lesions. Ann Neurol 1993, 33(2):137-151. doi: 10.1002/ana.410330203
11. Prineas JW, Connell F: Remyelination in multiple sclerosis. Ann Neurol 1979, 5(1):22-31. doi: 10.1002/ana.410050105
12. Raine CS, Wu E: Multiple sclerosis: remyelination in acute lesions. J Neuropathol Exp Neurol 1993, 52(3):199-204.
13. Chang A, Tourtellotte WW, Rudick R, Trapp BD: Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. NEnglJMed 2002, 346(3):165-173.
14. Chang A, Staugaitis SM, Dutta R, Batt CE, Easley KE, Chomyk AM, Yong VW, Fox RJ, Kidd GJ, Trapp BD: Cortical remyelination: a new target for repair therapies in multiple sclerosis. Ann Neurol 2012, 72(6):918-926. doi: 10.1002/ana.23693
15. Franklin RJ, Ffrench-Constant C: Remyelination in the CNS: from biology to therapy. Nature Rev Neurosci 2008, 9(11):839-855.
16. Kotter MR, Stadelmann C, Hartung HP: Enhancing remyelination in disease-can we wrap it up? Brain 2011, 134(Pt 7):1882-1900. doi: 10.1093/brain/awr014
17. Kremer D, Aktas O, Hartung HP, Kury P: The complex world of oligodendroglial differentiation inhibitors. Ann Neurol 2011, 69(4):602-618.
18. Ransohoff RM, Cardona AE: The myeloid cells of the central nervous system parenchyma. Nature 2010, 468(7321):253-262. doi: 10.1038/nature09615
19. Williams A, Piaton G, Lubetzki C: Astrocytes-friends or foes in multiple sclerosis? Glia 2007, 55(13):1300-1312. doi: 10.1002/glia.20546
20. Back SA, Tuohy TM, Chen H, Wallingford N, Craig A, Struve J, Luo NL, Banine F, Liu Y, Chang A, Trapp BD, Bebo BF Jr, Rao MS, Sherman LS: Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation. Nat Med 2005, 11(9):966-972.
21. Charles P, Hernandez MP, Stankoff B, Aigrot MS, Colin C, Rougon G, Zalc B, Lubetzki C: Negative regulation of central nervous system myelination by polysialylated-neural cell adhesion molecule. Proc Natl Acad Sci U S A 2000, 97(13):7585-7590. doi: 10.1073/pnas.100076197
22. Charles P, Reynolds R, Seilhean D, Rougon G, Aigrot MS, Niezgoda A, Zalc B, Lubetzki C: Re-expression of PSA-NCAM by demyelinated axons: an inhibitor of remyelination in multiple sclerosis? Brain 2002, 125(Pt 9):1972-1979.
23. Czopka T, Holst A, Ffrench-Constant C, Faissner A: Regulatory mechanisms that mediate tenascin C-dependent inhibition of oligodendrocyte precursor differentiation. J Neurosci 2010, 30(37):12310-12322.
24. John GR, Shankar SL, Shafit-Zagardo B, Massimi A, Lee SC, Raine CS, Brosnan CF: Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation. Nat Med 2002, 8(10):1115-1121.
25. Kremer D, Heinen A, Jadasz J, Gottle P, Zimmermann K, Zickler P, Jander S, Hartung HP, Kury P: p57kip2 is dynamically regulated in experimental autoimmune encephalomyelitis and interferes with oligodendroglial maturation. Proc Natl Acad Sci U S A 2009, 106(22):9087-9092.
26. Lau LW, Keough MB, Haylock-Jacobs S, Cua R, Doring A, Sloka S, Stirling DP, Rivest S, Yong VW: Chondroitin sulfate proteoglycans in demyelinated lesions impair remyelination. Ann Neurol 2012, 72(3):419-432. doi: 10.1002/ana.23599
27. Mi S, Miller RH, Lee X, Scott ML, Shulag-Morskaya S, Shao Z, Chang J, Thill G, Levesque M, Zhang M, Hession C, Sah D, Trapp B, He Z, Jung V, McCoy JM, Pepinsky RB: LINGO-1 negatively regulates myelination by oligodendrocytes. Nat Neurosci 2005, 8(6):745-751. doi: 10.1038/nn1460
28. Mohan H, Krumbholz M, Sharma R, Eisele S, Junker A, Sixt M, Newcombe J, Wekerle H, Hohlfeld R, Lassmann H, Meinl E: Extracellular matrix in multiple sclerosis lesions: fibrillar collagens, biglycan and decorin are upregulated and associated with infiltrating immune cells. Brain Pathol 2010, 20(5):966-975.
29. Piaton G, Aigrot MS, Williams A, Moyon S, Tepavcevic V, Moutkine I, Gras J, Matho KS, Schmitt A, Soellner H, Huber AB, Ravassard P, Lubetzki C: Class 3 semaphorins influence oligodendrocyte precursor recruitment and remyelination in adult central nervous system. Brain 2011, 134(Pt 4):1156-1167. doi: 10.1093/brain/awr022
30. Preston M, Gong X, Su W, Matsumoto SG, Banine F, Winkler C, Foster S, Xing R, Struve J, Dean J, Baggenstoss B, Weigel PH, Montine TJ, Back SA, Sherman LS: Digestion products of the PH20 hyaluronidase inhibit remyelination. Ann Neurol 2013, 73(2):266-280. doi: 10.1002/ana.23788
31. Williams A, Piaton G, Aigrot MS, Belhadi A, Theaudin M, Petermann F, Thomas JL, Zalc B, Lubetzki C: Semaphorin 3A and 3 F: key players in myelin repair in multiple sclerosis? Brain 2007, 130(Pt 10):2554-2565. doi: 10.1093/brain/awm202
32. Yuen TJ, Johnson KR, Miron VE, Zhao C, Quandt J, Harrisingh MC, Swire M, Williams A, McFarland HF, Franklin RJ, Ffrench-Constant C: Identification of endothelin 2 as an inflammatory factor that promotes central nervous system remyelination. Brain 2013, 136(Pt 4):1035-1047. doi: 10.1093/brain/awt024
33. Dutta R, Trapp BD: Gene expression profiling in multiple sclerosis brain. Neurobiol Dis 2012, 45(1):108-114. doi: 10.1016/j.nbd.2010.12.003
34. Steinman L, Zamvil S: Transcriptional analysis of targets in multiple sclerosis. Nat Rev Immunol 2003, 3(6):483-492.
35. Zeis T, Graumann U, Reynolds R, Schaeren-Wiemers N: Normal-appearing white matter in multiple sclerosis is in a subtle balance between inflammation and neuroprotection. Brain 2008, 131(Pt 1):288-303. doi: 10.1093/brain/awm291
36. Bansal R, Pfeiffer SE: Regulation of oligodendrocyte differentiation by fibroblast growth factors. Adv Exp Med Biol 1997, 429: 69-77.
37. Cohen RI, Chandross KJ: Fibroblast growth factor-9 modulates the expression of myelin related proteins and multiple fibroblast growth factor receptors in developing oligodendrocytes. J Neurosci Res 2000, 61(3):273-287.
38. Fortin D, Rom E, Sun H, Yayon A, Bansal R: Distinct fibroblast growth factor (FGF)/FGF receptor signaling pairs initiate diverse cellular responses in the oligodendrocyte lineage. J Neurosci 2005, 25(32):7470-7479.
39. Furusho M, Dupree JL, Nave KA, Bansal R: Fibroblast growth factor receptor signaling in oligodendrocytes regulates myelin sheath thickness. J Neurosci 2012, 32(19):6631-6641. doi: 10.1523/jneurosci. 6005-11.2012
40. Zhou YX, Pannu R, Le TQ, Armstrong RC: Fibroblast growth factor 1 (FGFR1) modulation regulates repair capacity of oligodendrocyte progenitor cells following chronic demyelination. Neurobiol Dis 2012, 45(1):196-205. doi: 10.1016/j.nbd.2011.08.004
41. Engele J, Bohn MC: Effects of acidic and basic fibroblast growth factors (aFGF, bFGF) on glial precursor cell proliferation: age dependency and brain region specificity. Dev Biol 1992, 152(2):363-372.
42. Elliott C, Lindner M, Arthur A, Brennan K, Jarius S, Hussey J, Chan A, Stroet A, Olsson T, Willison H, Barnett SC, Meinl E, Linington C: Functional identification of pathogenic autoantibody responses in patients with multiple sclerosis. Brain 2012, 135(Pt 6):1819-1833. doi: 10.1093/brain/aws105
43. Sorensen A, Alekseeva T, Katechia K, Robertson M, Riehle MO, Barnett SC: Long-term neurite orientation on astrocyte monolayers aligned by microtopography. Biomaterials 2007, 28(36):5498-5508. doi: 10.1016/j.biomaterials.2007.08.034
44. Thomson CE, Hunter AM, Griffiths IR, Edgar JM, McCulloch MC: Murine spinal cord explants: a model for evaluating axonal growth and myelination in vitro. J Neurosci Res 2006, 84(8):1703-1715. doi: 10.1002/jnr.21084
45. Birgbauer E, Rao TS, Webb M: Lysolecithin induces demyelination in vitro in a cerebellar slice culture system. J Neurosci Res 2004, 78(2):157-166. doi: 10.1002/jnr.20248
46. Miron VE, Jung CG, Kim HJ, Kennedy TE, Soliven B, Antel JP: FTY720 modulates human oligodendrocyte progenitor process extension and survival. Ann Neurol 2008, 63(1):61-71.
47. Eisele S, Krumbholz M, Fischer MT, Mohan H, Junker A, Arzberger T, Hohlfeld R, Bradl M, Lassmann H, Meinl E: Prospects of transcript profiling for mRNAs and microRNAs using formalin fixed and paraffin embedded dissected autoptic multiple sclerosis lesions. Brain Pathol 2012, 22(5):607-618.
48. Miron VE, Ludwin SK, Darlington PJ, Jarjour AA, Soliven B, Kennedy TE, Antel JP: Fingolimod (FTY720) enhances remyelination following demyelination of organotypic cerebellar slices. Am J Pathol 2010, 176(6):2682-2694.
49. Watkins TA, Emery B, Mulinyawe S, Barres BA: Distinct stages of myelination regulated by gamma-secretase and astrocytes in a rapidly myelinating CNS coculture system. Neuron 2008, 60(4):555-569. doi: 10.1016/j.neuron.2008.09.011
50. Aloisi F, Borsellino G, Samoggia P, Testa U, Chelucci C, Russo G, Peschle C, Levi G: Astrocyte cultures from human embryonic brain: characterization and modulation of surface molecules by inflammatory cytokines. J Neurosci Res 1992, 32(4):494-506.
51. Krumbholz M, Theil D, Derfuss T, Rosenwald A, Schrader F, Monoranu CM, Kalled SL, Hess DM, Serafini B, Aloisi F, Wekerle H, Hohlfeld R, Meinl E: BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma. J Exp Med 2005, 201(2):195-200.
52. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP: Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003, 4(2):249-264. doi: 10.1093/biostatistics/4.2.249
53. Smyth GK: Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004, 3: Article3. doi:10.2202/1544-6115.1027
54. Rudick RA, Mi S, Sandrock AW Jr: LINGO-1 antagonists as therapy for multiple sclerosis: in vitro and in vivo evidence. Expert Opin Biol Ther 2008, 8(10):1561-1570. doi: 10.1517/14712598.8.10.1561
55. Takami K, Matsuo A, Terai K, Walker DG, McGeer EG, McGeer PL: Fibroblast growth factor receptor-1 expression in the cortex and hippocampus in Alzheimer's disease. Brain Res 1998, 802(1-2):89-97.
56. Vargas MR, Pehar M, Cassina P, Martinez-Palma L, Thompson JA, Beckman JS, Barbeito L: Fibroblast growth factor-1 induces heme oxygenase-1 via nuclear factor erythroid 2-related factor 2 (Nrf2) in spinal cord astrocytes: consequences for motor neuron survival. J Biol Chem 2005, 280(27):25571-25579. doi: 10.1074/jbc.M501920200
57. Yayon A, Klagsbrun M, Esko JD, Leder P, Ornitz DM: Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell 1991, 64(4):841-848.
58. Gospodarowicz D, Cheng J: Heparin protects basic and acidic FGF from inactivation. J Cell Physiol 1986, 128(3):475-484. doi: 10.1002/jcp.1041280317
59. Spivak-Kroizman T, Lemmon MA, Dikic I, Ladbury JE, Pinchasi D, Huang J, Jaye M, Crumley G, Schlessinger J, Lax I: Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation. Cell 1994, 79(6):1015-1024. doi:http://dx.doi.org/10.1016/0092-8674(94)90032-9
60. Shao N, Wang H, Zhou T, Xue Y, Liu C: Heparin potentiation of the effect of acidic fibroblast growth factor on astrocytes and neurons. Life Sci 1994, 54(12):785-789. doi:http://dx.doi.org/10.1016/0024-3205(94)00447-1
61. Reuss B, von Bohlen und Halbach O: Fibroblast growth factors and their receptors in the central nervous system. Cell Tissue Res 2003, 313(2):139-157. doi: 10.1007/s00441-003-0756-7
62. Besnard F, Perraud F, Sensenbrenner M, Labourdette G: Effects of acidic and basic fibroblast growth factors on proliferation and maturation of cultured rat oligodendrocytes. Int J Dev Neurosci 1989, 7(4):401-409.
63. Furusho M, Kaga Y, Ishii A, Hebert JM, Bansal R: Fibroblast growth factor signaling is required for the generation of oligodendrocyte progenitors from the embryonic forebrain. J Neurosci 2011, 31(13):5055-5066. doi: 10.1523/jneurosci. 4800-10.2011
64. Elde R, Cao YH, Cintra A, Brelje TC, Pelto-Huikko M, Junttila T, Fuxe K, Pettersson RF, Hokfelt T: Prominent expression of acidic fibroblast growth factor in motor and sensory neurons. Neuron 1991, 7(3):349-364.
65. Kimura H, Tooyama I, McGeer PL: Acidic FGF expression in the surroundings of senile plaques. Tohoku J Exp Med 1994, 174(3):279-293.
66. Tourbah A, Baron-Van Evercooren A, Oliver L, Raulais D, Jeanny JC, Gumpel M: Endogenous aFGF expression and cellular changes after a demyelinating lesion in the spinal cord of adult normal mice: immunohistochemical study. J Neurosci Res 1992, 33(1):47-59. doi: 10.1002/jnr.490330107
67. Fancy SP, Harrington EP, Yuen TJ, Silbereis JC, Zhao C, Baranzini SE, Bruce CC, Otero JJ, Huang EJ, Nusse R, Franklin RJ, Rowitch DH: Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination. Nat Neurosci 2011, 14(8):1009-1016. doi: 10.1038/nn.2855
68. Kelland EE, Gilmore W, Weiner LP, Lund BT: The dual role of CXCL8 in human CNS stem cell function: multipotent neural stem cell death and oligodendrocyte progenitor cell chemotaxis. Glia 2011, 59(12):1864-1878. doi: 10.1002/glia.21230
69. Omari KM, John GR, Sealfon SC, Raine CS: CXC chemokine receptors on human oligodendrocytes: implications for multiple sclerosis. Brain 2005, 128(Pt 5):1003-1015.
70. Semple BD, Kossmann T, Morganti-Kossmann MC: Role of chemokines in CNS health and pathology: a focus on the CCL2/CCR2 and CXCL8/CXCR2 networks. J Cereb Blood Flow Metable 2010, 30(3):459-473. doi: 10.1038/jcbfm.2009.240
71. Nguyen D, Stangel M: Expression of the chemokine receptors CXCR1 and CXCR2 in rat oligodendroglial cells. Dev Brain Res 2001, 128(1):77-81. doi:http://dx.doi.org/10.1016/S0165-3806(01)00128-6
72. Mayer M, Bhakoo K, Noble M: Ciliary neurotrophic factor and leukemia inhibitory factor promote the generation, maturation and survival of oligodendrocytes in vitro. Development 1994, 120(1):143-153.
73. Barres BA, Schmid R, Sendnter M, Raff MC: Multiple extracellular signals are required for long-term oligodendrocyte survival. Development 1993, 118(1):283-295.
74. Butzkueven H, Zhang J-G, Soilu-Hanninen M, Hochrein H, Chionh F, Shipham KA, Emery B, Turnley AM, Petratos S, Ernst M, Bartlett PF, Kilpatrick TJ: LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival. Nat Med 2002, 8(6):613-619.
75. Kerr BJ, Patterson PH: Leukemia inhibitory factor promotes oligodendrocyte survival after spinal cord injury. Glia 2005, 51(1):73-79. doi: 10.1002/glia.20177
76. Ishibashi T, Dakin KA, Stevens B, Lee PR, Kozlov SV, Stewart CL, Fields RD: Astrocytes promote myelination in response to electrical impulses. Neuron 2006, 49(6):823-832.
77. Laterza C, Merlini A, De Feo D, Ruffini F, Menon R, Onorati M, Fredrickx E, Muzio L, Lombardo A, Comi G, Quattrini A, Taveggia C, Farina C, Cattaneo E, Martino G: iPSC-derived neural precursors exert a neuroprotective role in immune-mediated demyelination via the secretion of LIF. Nat Commun 2013, 4: 2597. doi: 10.1038/ncomms3597
78. Chari DM: Remyelination in multiple sclerosis. Int Rev Neurobiol 2007, 79: 589-620. doi: 10.1016/s0074-7742(07)79026-8
79. Syed YA, Hand E, Mobius W, Zhao C, Hofer M, Nave KA, Kotter MR: Inhibition of CNS remyelination by the presence of semaphorin 3A. J Neurosci 2011, 31(10):3719-3728. doi: 10.1523/jneurosci. 4930-10.2011
80. Beenken A, Mohammadi M: The FGF family: biology, pathophysiology and therapy. Nat Rev Drug Discov 2009, 8(3):235-253. doi: 10.1038/nrd2792